Does the product work and address real needs----YesDo we have...

Does the product work and address real needs----Yes
Do we have real patient proof of concept--------Yes
Is this a better alternative treatment to the current standard of care--------------------------------Absolutely
Is there insurance company benefits to this-----guaranteed
We now know we got a whopper of a product that can sell volumes in the billions with literally no competition but lets look at the parameters:
we have 16 employees and we need to execute this as soon as humanly possible.
The DVEous graph of a few posts ago shows that in 2004 the world knew this was the magic bullet----what the world learned as the stock went down was the previous management blew it and the graph shows a long aimless walk in the wilderness was to follow,
Yesterdays scars news and this weeks press clearly show we just formally arrived---this is all about execution of trials for a product of multiple sales channel benefits.
Folks---i have that warm fuzzy feeling that we now need to count patients through trials and all the trials. If you were the CEO of the miracle product/cure i can assure you when FDA approval comes ReCell will be on an automatic reorder system in every hospital and clinic across the whole world.Count trial patients and not sales----the medical pros already know the sales will be in the billions when we get the trials completed and stop concentrating on quarterlies-----they just got out of the wilderness---Gizzard said it right ---the trajectory does call for a 10MM volume day with a 30% rise and when the professional funds are out of bullets double that the next time.Put this stock certificate in your drawer and look at it around Christmas time----DVEous------wait till you see the graph trajectory about then and we all can fill in the blanks a year later----trial trials trials----when the field is built they all will play. BD---muy bien mate!!!!